viral proteases Kaiserman and Bird 2005) .
In 2001, we identified one of the last human clade B serpins, SERPINB12 (Askew et al. 2001) . SERPINB12 is a potent inhibitor of trypsin-like proteases and by RT-PCR appeared to have a wide tissue distribution pattern (Askew et al. 2001) . Because most of the other human clade B serpins are more restricted in their tissue expression, we sought to better define expression of SERPINB12 by generating a monoclonal antibody (MAb). While we were preparing to examine the specificity of this IgG1 mouse anti-human SERPINB12 monoclonal antibody in depth, this reagent was used to define the SERPINB12 distribution pattern as part of a tissue-based expression map of the human proteome (Uhlen et al. 2015) , as part of the Human Protein Atlas project (www.proteinatlas.org). The goal of this study was to delineate the specificity of our mouse anti-human SERPINB12 monoclonal antibody and confirm and possibly expand this serpin's tissue and cellular distribution using blocking studies and a broader array of tissue samples. We show that this monoclonal antibody was specific for human SERPINB12 and did not interact with mouse Serpinb12 or other types of human clade B serpins. SERPINB12 was detected in the epithelium of the gastrointestinal, respiratory, and reproductive tracts. In addition, SERPINB12 was highly expressed in the liver and many glandular tissues of the endocrine and reproductive systems. Taken together, we concluded SERPINB12 is broadly expressed and is likely to protect cells from both endogenous and exogenous peptidases.
Materials and Methods

Production of Recombinant Serpin Proteins
Both human SERPINB12 and mouse Serpinb12 cDNAs were amplified using primers (human forward, 5′-TACTC GGATCCATGGACTCTCTTGTTACAGCAAACACC-3′; reverse,5′-TCGTACTCGAGTTAAGGAGAGCAGAC CCTGCC-3′; mouse forward, 5′-CGGATCCGTAACCAG TTTTACAATGGAC-3′; reverse, 5′-ATAAGAATGCGG C C G C G C C A G A G TA G AT T C A A G G G C -3 ′ ) t h a t facilitated an in-frame insertion into the PGEX-6P bacterial expression vector (GE Healthcare; Piscataway, NJ). The amplified human SERPINB12 product was cloned using the restriction endonculeases BamHI and XhoI, and the mouse Serpinb12 product was cloned using BamHI and NotI restriction enzymes (New England BioLabs; Ipswich, MA). DNA sequencing (Genewiz; South Plainfield, NJ) verified both coding sequences were inserted in-frame.
The human GST-SERPINB12 and mouse GST-Serpinb12 recombinant proteins were purified from BL21 Escherichia coli (Amsbio; Lake Forest, CA). Bacterial cells were inoculated in 10 ml 2XY broth (16 g tryptone, 10 g yeast extract, 5 g NaCl in 1 L water) containing 100 µg/µl ampicillin overnight at 37C. Overnight culture was diluted 1 in 50 into fresh 2XY containing 100 µg/µl ampicillin and shaken at 37C until A 600 = 0.4 to 0.6. The cells were then removed and shaken at room temperature for another 4 hr without IPTG induction. Cells were collected by centrifugation (4000 × g for 30 min at 4C). Cells were lysed using SoluLyse reagent (Amsbio; Lake Forest, CA) with addition of cOmplete protease-inhibitor cocktail (Roche Life Sciences; Indianapolis, IN). The cellular debris was pelleted by centrifugation (12,000 × g for 10 min at 4C), and the resultant supernatant was added to Glutathione Sepharose 4B (GE Healthcare; Indianapolis, IN). GST-SERPINB12 and GST-Serpinb12 were eluted off Sepharose using GST elution buffer (10 mM reduced glutathione, 50 mM Tris-HCL [pH 8], 100 mM NaCl).
Human recombinant, GST-SERPINB3 (GST-SCCA1), GST-SERPINB4 (GST-SCCA2), and GST-SERPINB13 were generated as described previously (Schick et al. 1997; Schick et al. 1998; Jayakumar et al. 2003) . 6× His-SERPINB2 was purchased from ProteinTech (Chicago, IL).
Generation of MAbs Specific for SERPINB12
Monoclonal antibodies were produced in mice by Cell Essentials (Boston, MA) using full-length recombinant 6× His-SERPINB12 antigen. Hybridomas were screened using recombinant GST-SERPINB12 protein. Monoclonal antibodies were collected from hybridoma culture supernatants.
Isotyping of MAbs
Purified antibodies were screened for isotype using an ELISA-based mouse immunoglobulin isotyping kit (Life Technologies; Grand Island, NY) as per the manufacturer's instructions.
Specificity of SERPINB12 MAbs by Immunoblotting
The recombinant proteins 6× His-SERPINB2, GST-SERPINB3, GST-SERPINB4, GST-SERPIN B12, GST-Serpinb12, and GST-SERPINB13 were separated by SDS-PAGE and immunoblotted using the purified mouse monoclonal SERPINB12 antibody (H3-1B MAb) at 1:5000 dilution, a monoclonal GST-antibody (Thermo Scientific; Waltham, MA) at 1:1000 dilution, or a monoclonal His antibody (GE Healthcare Lifesciences; Pittsburgh, PA) at 1:1000 dilution. All antibodies were diluted with Tris-buffered saline (TBS; 137 mM NaCl, 27 mM KCl, 10 mM Tris-HCl [pH 7.4]) + 0.1% Tween 20 (Sigma-Aldrich; St. Louis, MO) + 1% Block (Bio-Rad; Hercules, CA). All subsequent wash steps were performed as directed by manufacturer instructions. After washing, the primary antibody binding was detected with peroxidase-conjugated bovine anti-mouse (Santa Cruz Biotechnology, Dallas, TX). Signal was detected using Super Signal West Pico Chemiluminescent Substrate (Thermo Scientific) and autoradiography.
Specificity of SERPINB12 MAb by Immunohistochemistry
To determine the specificity of the H3-1B MAb in immunohistochemical staining, tissue arrays were treated as below using the following primary antibody conditions: H3-1B MAb (1 in 100), mouse IgG1 (Dako, Carpinteria, CA) (1 in 100 dilution), or a blocked control, which consisted of preincubation of the H3-1B MAb with recombinant GST-SERPINB12 in a 1:1 molar ratio for 2 hr at 25C prior to diluting 1 in 100 in phosphate-buffered saline (PBS; 137 mM NaCl, 27 mM KCl, 10 mM phosphate buffer [pH 7.4]) + 0.5% BSA. Subsequent primary antibody detection steps were completed as below.
Immunohistochemistry
Commercial multiorgan tissue arrays were purchased from Pantomics (Richmond, CA). The arrays were heated to 60C for 30 min and then deparaffinized using two 5-min xylene washes. Arrays were rehydrated by soaking in 100% ethanol twice for 2 min, 95% ethanol for 5 min, 70% ethanol for 5 min, and finally water for 5 min. Antigen retrieval was performed by boiling arrays in 10 mM citric acid for 10 min. Arrays were blocked in 1% BSA (Sigma-Aldrich) and 5% donkey serum (Santa Cruz Biotechnology) in PBS for 60 min. Primary H3-1B MAb was diluted 1:100 in PBS containing 0.5% BSA and incubated overnight at 4C. Negative control arrays (Secondary alone) were incubated with 0.5% BSA in PBS at 4C. Secondary antibody donkey anti-mouse IgG-HRP (Santa Cruz Biotechnologies) diluted 1:200 in PBS containing 0.5% BSA was incubated with arrays for 60 min. Arrays were then stained with a DAB kit (Vector Laboratories, Burlington, CA) and hematoxylin (Thermo Scientific) as per the manufacturer's instructions. Tissue arrays were then mounted in watersoluble Gelvatol mounting media (0.2 M Tris base [Thermo Fisher Scientific, Waltham, MA], pH 8.5; polyvinyl alcohol [Sigma-Aldrich]; and glycerol [Sigma-Aldrich] added to appropriate consistency) and imaged using an Olympus BH2 microscope (Olympus, Pennsylvania, PA) mounted with a Jenoptik ProgRes C5 camera (Jenoptik AG, Jena, Germany). Images were acquired using ProgRes CapturePro 2.7 software (Jenoptik AG). Images were enhanced (color balance and contrast) for clarity and cropped using Adobe Photoshop (v13.0; Adobe Systems, San Jose, CA).
Results
Characterization of Anti-SERPINB12 MAb
The H3-1B antibody was determined to be an IgG1 kappa light chain mouse monoclonal antibody. Because human SERPINB12 is most similar to the mouse orthologue, Serpinb12, and the SERPINB4, -B3, and -B13 clade B serpins (Suppl. Table S1), to determine the specificity of the mouse IgG1 H3-1B MAb, we probed parallel immunoblots containing the recombinant serpins 6×His-SERPINB2 (lane 1), GST-SERPINB3 (lane 2), -B4 (lane 3), -B12 (lane 4), -B13 (lane 5), and mouse GST-Serpinb12 (lane 6). The H3-1B MAb detected a band of approximately 72 kDa only in the lane containing GST-SERPINB12 ( Fig. 1A) . Monoclonal antibodies against GST ( Fig. 1B) and 6×His (Fig. 1C ) epitope tags served as positive controls for the recombinant GST and His fusion proteins, respectively. A companion Coomassie-stained SDS-PAGE gel confirmed that equivalent amounts of protein were loaded onto the gel (Fig. 1C ). These data suggested that the H3-1B MAb only detected SERPINB12 and did not cross-react with other types of clade B serpins and is species specific.
To determine specificity of the antibody by immunohistochemical methods, tissue arrays were incubated with mouse IgG1 ( Fig. 2A ,D,G), H3-1B MAb (Fig. 2C ,F,I), and H3-1B MAb preincubated with recombinant GST-SERPINB12 in a 1:1 molar ratio for 2 hr at 25C (Fig.  2B ,E,H). Staining is only seen in the H3-1B MAb-alone treated tissue array. In separate sets of experiments using different types of tissues, the specificity of the primary antibody MAb was controlled for by substitution with either mouse IgG1 or an unrelated monoclonal antibody (CD163) (data not shown). Similarly, the blocking experiments with GST-SERPINB12 were controlled for by substitution with BSA. None of the other primary antibodies gave a signal, and BSA did not block the activity of H3-1B (data not shown). Taken together, these data confirmed that that the H3-1B MAb was highly specific for human SERPINB12 in tissue samples.
Immunohistochemical Analysis of Human Tissues Using a SERPINB12-Specific MAb
SERPINB12 is expressed in several different cell types of virtually all tissues examined. Of particular interest due to its potential role as a cytoprotective protease inhibitor are the environmentally exposed epithelia of the digestive tract, respiratory tract, and skin. SERPINB12 was found in the squamous epithelium of the esophagus (Fig. 3A) , the foveolar epithelium of the stomach (Fig. 3B) , and the epithelium of the small intestine ( Fig. 3C) , colon (Fig. 3D ), and rectum ( Fig. 3E ). In the respiratory tract, SERPINB12 is expressed in the alveolar macrophages ( Fig. 4A ), the bronchus, conducting airways, and alveolar epithelium (pneumocytes; Fig. 4B ), as well as the epithelium of the trachea (Fig. 4C ). SERPINB12 is also expressed in the epithelial layer of the skin (Fig. 5C ). In addition to these epithelial tissues, SERPINB12 was found in multiple tissue and cell types with varying levels of expression (Table 1) 
Expression of SERPINB12 by System
Musculoskeletal System. SERPINB12 was moderately expressed in myocytes of skeletal muscle and weakly detected in the hematopoietic cells of bone marrow.
Cardiovascular System. In the heart, SERPINB12 was moderately expressed and localized to the cardiomyocytes (Fig. 5A) .
Digestive System. SERPINB12 was expressed in all tissues of the digestive system as discussed above. In addition to the epithelia, SEPRINB12 was mildly expressed in the smooth muscle of the esophagus (Fig. 4A ) and hepatocytes of the liver (Fig. 5B ).
Skin. SERPINB12 was expressed at low levels in both the squamous epithelium and eccrine duct epithelium (Fig. 5C ).
Endocrine System. SERPINB12 was mildly expressed in acinar cells and duct cells of pancreas. In addition, lowlevel expression was seen in the pituicytes of the pituitary gland and the follicular epithelium of the thyroid. Interestingly, moderate diffuse staining was seen in cortical cells within the adrenal gland.
Female Reproductive System. Low-level SERPINB12 expression levels were detected in the endometrium and smooth muscle of the uterus, the fibrovascular tissue of the ovary, the epithelium, vascular tissue, smooth muscle of the fallopian tube, and large duct epithelium and terminal duct lobular unit of the breast.
Male Reproductive System. SERPINB12 was detected at low levels in fibromuscular stroma of the prostate, as well as the Leydig and Sertoli cells of the testis.
Urinary Tract. High expression levels of SERPINB12 were detected in tubular epithelium of the kidney (Fig. 5D ). In Lung/Respiratory System. In addition to the moderate expression detected in epithelium throughout respiratory tract discussed above, SERPINB12 was also found in both smooth muscle and alveolar macrophages.
Other Systems. Mild expression of SERPINB12 was detected in macrophages and epithelium of the thymus. Low-level expression of this serpin was also seen in the cytotrophoblasts of the placenta, as well as the squamous epithelium and macrophages of the tonsils. No expression of SERPINB12 was detected in the spleen.
Discussion
SERPINB12 is a human clade B/intracellular inhibitor of trypsin-like proteinases and shares a ~40% to 50% amino acid identity with the other 12 family members (Askew et al. 2001 ). SERPINB12 also shares ~70% primary amino acid identity with its mouse orthologue ). The MAbs raised against SERPINB12 were isotyped and screened for broad specificity via immunoblotting. Of the MAbs raised, the IgG1 H3-1B MAb was the most specific under limited conditions. Further examination of the specificity of MAb H3-1B by immunoblotting and immunohistochemistry showed that this HRP secondary antibody was detected using the DAB peroxidase detection kit. Positive staining is only seen in the H3-1B tissues. Scale bar = 100 µm. Images were captured on an Olympus BH2 microscope mounted with a Jenoptik ProgRes C5 camera. Images were acquired using ProgRes CapturePro 2.7 software. Figure 3 . Respiratory tract. SERPINB12 staining in the lung and tracheobronchial tree showed that the distal alveolated lung parenchyma had little staining of alveolar lining cells (A) but did highlight alveolar macrophages (inset) and some endothelium of interstitial blood vessels. The bronchial (B) and tracheal (C) epithelium in general demonstrated weak intensity and variable distribution of cytoplasmic staining. Upon closer inspection, some bronchial epithelial cells appeared to demonstrate nuclear staining; however, this may be related to the overlapping nature of the pseudostratified epithelium (inset). Scale bar = 100 µm. Images were captured on an Olympus BH2 microscope mounted with a Jenoptik ProgRes C5 camera. Images were acquired using ProgRes CapturePro 2.7 software. MAb was specific for human SERPINB12. Although not all clade B serpins were examined for cross-reactivity, the orthologous mouse Serpinb12, the three human clade B serpins with the highest amino acid identity, and the outlier SERPINB2 were not detected by immunoblotting of recombinant proteins. Moreover, preincubation of the H3-1B MAb with recombinant human GST-SERPINB12 abolished all staining by immunohistochemistry. These data suggest that the H3-1B MAb is specific for human SERPINB12 and does not cross-react with its mouse orthologue or any of the human clade B serpins tested.
The H3-1B MAb was licensed to a commercial vendor (Santa Cruz Biotechnology) and used by the Human Protein Atlas project (HPA; www.proteinatlas.org). Using different tissue samples and immunohistochemical techniques, we demonstrated that there was excellent concordance in the tissue distribution profiles between our studies and those described by the HPA (Uhlen et al. 2015) . However, we detected SERPINB12 in the ovaries, where it was not detected in the HPA study in this organ. In addition, we detected SERPINB12 expression in the thymus and trachea, which was not studied in the HPA project. Additionally, the overall expression levels were similar between the two studies, with some notable exceptions: the adrenal gland, cerebellum, and stomach were scored as high-level expression by the HPA, whereas in our study, these organs were given a low-medium expression level score. In the current study, the organ with highest expression score was the kidney, with expression restricted to the tubular epithelium. Moreover, subtle differences exist in the cell-type specificity in some of the organs. For example, in the bladder, we detected SERPINB12 only in the detrusor muscle cells, whereas the HPA states expression in urothelial cells. Many of the small discrepancies can be attributed to the different sections used for the two separate studies, and thus, these data together can provide a much more complete expression profile of this almost ubiquitously expressed intracellular serpin. In addition, there is a good correlation with the RT-PCR data previously published by our laboratory, with almost all tissues having detectable mRNA levels except thymus, colon, and skeletal muscle (Askew et al. 2001 ). All these tissues were positive in our immunohistochemical survey with the H3-1B MAb, as well as in the HPA database, at low to medium levels. Also of note, the spleen was positive for mRNA levels but was negative by immunohistochemistry in both studies. There is growing evidence that there is often poor correlation of protein and mRNA levels due to mRNA decay, translation, and protein degradation (Lundberg et al. 2010; Vogel et al. 2010; Schwanhausser et al. 2011; Schwanhausser et al. 2013) .
SERPINB12 was primarily expressed in the epithelia of most organs, including the respiratory tract, the digestive system, and skin. This is similar to the tissue and cell-type expression profile of some of the other human intracellular serpin members (e.g., SERPINB3, -B4, -B6, and -B13) detected within the epithelia exposed to the environment ). However, subtle differences exist. For example, SERPINB3 and -B4 were coexpressed in the suprabasal layers of stratified squamous epithelium (Cataltepe, Gornstein, et al. 2000) , whereas SERPINB12 was expressed in both the suprabasal and basal layers. Unlike the other intracellular serpins, SERPINB12 was also expressed in the liver parenchyma, multiple endocrine tissues, and a restricted set of central nervous system tissues and kidney/urinary collecting system. Of note, the only tissue where SERPINB12 was not detected in this survey was the spleen.
SERPINB12 was detected in multiple sites within the lung. In addition to the epithelial cells, this serpin was also expressed in alveolar macrophages. These macrophages harbor and secrete a multitude of elastinolytic proteases to digest the extracellular matrix during infection. These proteases include the trypsin-like serine proteases (Russell et al. 2002) such as human airway trypsin-like protease (Orikawa et al. 2012) , which may be potential targets of SERPINB12 based on its in vitro protease inhibitory profile (Askew et al. 2001) . This localization of SERPINB12 may suggest that this serpin could play a cytoprotective role of macrophages from its own endogenous proteases along with other protease inhibitors. In addition, unlike previously described clade B serpins (Cataltepe, Gornstein, et al. 2000) , SERPINB12 was detected in airway epithelium, including pneumocytes. These epithelial cells have multiple roles, including surfactant production. This suggests that SERPINB12 may have roles in multiple biological processes such as protein processing.
SERPINB12 is an inhibitor of trypsin and plasmin in vitro (Askew et al. 2001) , which are produced and secreted from the pancreas and liver, respectively. These organs also express high levels of SERPINB12, suggesting that this serpin may also play a cytoprotective role in pancreatic cells (0), mild (1), moderate (2), or strong (3). Scores given are average of multiple sections and tissue arrays (n≥2). b From the Human Protein Atlas (HPA; www.proteinatlas.org).
(continued) and hepatocytes from endogenous proteolytic digestion via these two highly active and pervasive enzymes. The abundant tissue distribution of SERPINB12 suggests that this intracellular serpin has an extremely important physiological role. Its expression in both the epithelia and the macrophages suggests a role in host defense, either by inhibition of exogenous viral and bacterial proteases or a cytoprotective role of vital cells from endogenous proteases needed to combat infection. In addition, the expression of SERPINB12 in the same tissues as its in vitro protease targets suggests a cytoprotective role of the secretory cells producing these enzymes.
In summary, we have described the intensity and extent of SERPINB12 expression using immunohistochemistry in a wide array of human organs and tissues. The expression of SERPINB12 in virtually all tissues suggests that this intracellular serpin may have diverse and wide-ranging biological roles and may be an important therapeutic target for multiple disease processes.
